Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Walker

Showing results (61-70 of 218) with videos related to

Pageof 22
Sort By:
Metabolism: Clinical and Experimental|May 22, 2003
Predicting cardiovascular risk factors from plasma cortisol measured during oral glucose tolerance testsRebecca M Reynolds, Holly E Syddall, Brian R Walker, et al.
Diabetes|January 27, 2011
Increased whole-body and sustained liver cortisol regeneration by 11beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibitionRoland H Stimson, Ruth Andrew, Norma C McAvoy, et al.
Endocrinology|June 18, 2003
Obese Zucker rats have reduced mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 1 expression in hippocampus-implications for dysregulation of the hypothalamic-pituitary-adrenal axis in obesityCecilia Mattsson, Maggie Lai, June Noble, et al.
Clinical Endocrinology|May 3, 2006
Differences in cortisol concentrations in South Asian and European men living in the United KingdomRebecca M Reynolds, Colin Fischbacher, Raj Bhopal, et al.
Endocrinology|February 6, 2010
Prenatal dexamethasone programs expression of genes in liver and adipose tissue and increased hepatic lipid accumulation but not obesity on a high-fat dietAmanda J Drake, Peter J Raubenheimer, David Kerrigan, et al.
Diabetes|March 1, 2005
Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxoloneThekkepat C Sandeep, Ruth Andrew, Natalie Z M Homer, et al.
Statistical Methods in Medical Research|October 2, 2015
Development of a Bayesian response-adaptive trial design for the Dexamethasone for Excessive Menstruation studyChristian Holm Hansen, Pamela Warner, Richard A Parker, et al.
European Journal of Endocrinology|April 19, 2014
Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 in overweight/obese women with polycystic ovary syndrome compared with weight-matched controlsAlessandra Gambineri, Flaminia Fanelli, Federica Tomassoni, et al.
Plos One|December 31, 2009
Tissue-specific increases in 11beta-hydroxysteroid dehydrogenase type 1 in normal weight postmenopausal womenTherése Andersson, Kotryna Simonyte, Ruth Andrew, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 23, 2009
Quantitative analysis of RU38486 (mifepristone) by HPLC triple quadrupole mass spectrometryNatalie Z M Homer, Rebecca M Reynolds, Cecilia Mattsson, et al.
Pageof 22

Showing results (61-70 of 218) with videos related to

Sort By:
Pageof 22
Metabolism: Clinical and Experimental|May 22, 2003
Predicting cardiovascular risk factors from plasma cortisol measured during oral glucose tolerance testsRebecca M Reynolds, Holly E Syddall, Brian R Walker, et al.
Diabetes|January 27, 2011
Increased whole-body and sustained liver cortisol regeneration by 11beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibitionRoland H Stimson, Ruth Andrew, Norma C McAvoy, et al.
Endocrinology|June 18, 2003
Obese Zucker rats have reduced mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 1 expression in hippocampus-implications for dysregulation of the hypothalamic-pituitary-adrenal axis in obesityCecilia Mattsson, Maggie Lai, June Noble, et al.
Clinical Endocrinology|May 3, 2006
Differences in cortisol concentrations in South Asian and European men living in the United KingdomRebecca M Reynolds, Colin Fischbacher, Raj Bhopal, et al.
Endocrinology|February 6, 2010
Prenatal dexamethasone programs expression of genes in liver and adipose tissue and increased hepatic lipid accumulation but not obesity on a high-fat dietAmanda J Drake, Peter J Raubenheimer, David Kerrigan, et al.
Diabetes|March 1, 2005
Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxoloneThekkepat C Sandeep, Ruth Andrew, Natalie Z M Homer, et al.
Statistical Methods in Medical Research|October 2, 2015
Development of a Bayesian response-adaptive trial design for the Dexamethasone for Excessive Menstruation studyChristian Holm Hansen, Pamela Warner, Richard A Parker, et al.
European Journal of Endocrinology|April 19, 2014
Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 in overweight/obese women with polycystic ovary syndrome compared with weight-matched controlsAlessandra Gambineri, Flaminia Fanelli, Federica Tomassoni, et al.
Plos One|December 31, 2009
Tissue-specific increases in 11beta-hydroxysteroid dehydrogenase type 1 in normal weight postmenopausal womenTherése Andersson, Kotryna Simonyte, Ruth Andrew, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 23, 2009
Quantitative analysis of RU38486 (mifepristone) by HPLC triple quadrupole mass spectrometryNatalie Z M Homer, Rebecca M Reynolds, Cecilia Mattsson, et al.
Pageof 22